

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of regulatory T cell differentiation (GO:0045589) | 9.66298238 |
| 2 | tolerance induction (GO:0002507) | 7.33325948 |
| 3 | * negative regulation of B cell proliferation (GO:0030889) | 7.31795621 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.96763648 |
| 5 | * regulation of chronic inflammatory response (GO:0002676) | 6.14058439 |
| 6 | positive regulation of heat generation (GO:0031652) | 5.84951380 |
| 7 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.80652741 |
| 8 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.75688955 |
| 9 | regulation of fever generation (GO:0031620) | 5.62632525 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.58416962 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.58416962 |
| 12 | regulation of vitamin metabolic process (GO:0030656) | 5.44366846 |
| 13 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.23159373 |
| 14 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.16774054 |
| 15 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.93887016 |
| 16 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.93887016 |
| 17 | regulation of heat generation (GO:0031650) | 4.65531440 |
| 18 | leukocyte aggregation (GO:0070486) | 4.64582710 |
| 19 | type I interferon signaling pathway (GO:0060337) | 4.53838056 |
| 20 | cellular response to type I interferon (GO:0071357) | 4.53838056 |
| 21 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.50085181 |
| 22 | response to type I interferon (GO:0034340) | 4.47880895 |
| 23 | * regulation of B cell proliferation (GO:0030888) | 4.43781258 |
| 24 | * negative regulation of B cell activation (GO:0050869) | 4.36359626 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 4.34772042 |
| 26 | glial cell proliferation (GO:0014009) | 4.31761401 |
| 27 | T-helper cell differentiation (GO:0042093) | 4.31488476 |
| 28 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.31488476 |
| 29 | response to peptidoglycan (GO:0032494) | 4.29596531 |
| 30 | * negative regulation of interleukin-12 production (GO:0032695) | 4.27545837 |
| 31 | regulation of chemokine biosynthetic process (GO:0045073) | 4.26891017 |
| 32 | response to interleukin-15 (GO:0070672) | 4.24599636 |
| 33 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.23305111 |
| 34 | defense response to protozoan (GO:0042832) | 4.21765401 |
| 35 | negative regulation of T cell differentiation (GO:0045581) | 4.20162006 |
| 36 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.18364134 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.17675993 |
| 38 | negative thymic T cell selection (GO:0045060) | 4.11429792 |
| 39 | regulation of podosome assembly (GO:0071801) | 4.10101088 |
| 40 | lymphocyte costimulation (GO:0031294) | 4.08912143 |
| 41 | negative T cell selection (GO:0043383) | 4.02300463 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97112952 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.97112952 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97112952 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97112952 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97112952 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.97112952 |
| 48 | response to protozoan (GO:0001562) | 3.96110986 |
| 49 | negative regulation of amino acid transport (GO:0051956) | 3.93311858 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.90688684 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 3.89415417 |
| 52 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.88299036 |
| 53 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.87046806 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.85844447 |
| 55 | T-helper 1 type immune response (GO:0042088) | 3.83990902 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.82120461 |
| 57 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.79325760 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.78808027 |
| 59 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.77635073 |
| 60 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.77635073 |
| 61 | T cell differentiation involved in immune response (GO:0002292) | 3.77635073 |
| 62 | positive regulation of defense response to virus by host (GO:0002230) | 3.74431869 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.72605911 |
| 64 | regulation of T-helper cell differentiation (GO:0045622) | 3.72484201 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72114241 |
| 66 | positive regulation of interferon-alpha production (GO:0032727) | 3.71421921 |
| 67 | * regulation of interferon-alpha production (GO:0032647) | 3.71421921 |
| 68 | positive regulation of isotype switching (GO:0045830) | 3.71239461 |
| 69 | T cell costimulation (GO:0031295) | 3.70199201 |
| 70 | T cell migration (GO:0072678) | 3.68078418 |
| 71 | positive thymic T cell selection (GO:0045059) | 3.66009475 |
| 72 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.65547641 |
| 73 | cytokine production involved in immune response (GO:0002367) | 3.65145052 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.65056241 |
| 75 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.63991496 |
| 76 | T cell lineage commitment (GO:0002360) | 3.63925576 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.63631928 |
| 78 | * negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.56880944 |
| 79 | macrophage activation involved in immune response (GO:0002281) | 3.56331633 |
| 80 | T cell selection (GO:0045058) | 3.55815858 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 3.55495364 |
| 82 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.55291753 |
| 83 | cellular response to nicotine (GO:0071316) | 3.55119047 |
| 84 | * regulation of cytokine secretion involved in immune response (GO:0002739) | 3.53375091 |
| 85 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.52948929 |
| 86 | thymic T cell selection (GO:0045061) | 3.51254099 |
| 87 | positive regulation of type 2 immune response (GO:0002830) | 3.50487668 |
| 88 | production of molecular mediator of immune response (GO:0002440) | 3.49680548 |
| 89 | germinal center formation (GO:0002467) | 3.48678191 |
| 90 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 3.47996762 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 3.47190943 |
| 92 | negative regulation of osteoclast differentiation (GO:0045671) | 3.46999382 |
| 93 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.46841956 |
| 94 | positive regulation of acute inflammatory response (GO:0002675) | 3.46648702 |
| 95 | negative regulation of adaptive immune response (GO:0002820) | 3.46405036 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45781955 |
| 97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45781955 |
| 98 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.42105348 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.41799007 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40739764 |
| 101 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.40003398 |
| 102 | positive regulation of B cell differentiation (GO:0045579) | 3.39993572 |
| 103 | * regulation of MHC class II biosynthetic process (GO:0045346) | 3.37955089 |
| 104 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.35880224 |
| 105 | modulation by symbiont of host cellular process (GO:0044068) | 3.35854430 |
| 106 | positive regulation of interleukin-12 production (GO:0032735) | 3.34538086 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 3.33804331 |
| 108 | monocyte chemotaxis (GO:0002548) | 3.29459615 |
| 109 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.28089911 |
| 110 | positive regulation of B cell mediated immunity (GO:0002714) | 3.26927742 |
| 111 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.26927742 |
| 112 | adhesion of symbiont to host cell (GO:0044650) | 3.25874431 |
| 113 | virion attachment to host cell (GO:0019062) | 3.25874431 |
| 114 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.25402154 |
| 115 | positive regulation of immunoglobulin production (GO:0002639) | 3.24991860 |
| 116 | activation of MAPKKK activity (GO:0000185) | 3.23115613 |
| 117 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.22625917 |
| 118 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.21688515 |
| 119 | * regulation of interleukin-12 production (GO:0032655) | 3.21631889 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 3.20377739 |
| 121 | regulation of B cell differentiation (GO:0045577) | 3.20164913 |
| 122 | * regulation of B cell activation (GO:0050864) | 3.20070739 |
| 123 | regulation of interleukin-13 production (GO:0032656) | 3.20032830 |
| 124 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.18418308 |
| 125 | regulation of T-helper 1 type immune response (GO:0002825) | 3.18199261 |
| 126 | * cellular response to lipopolysaccharide (GO:0071222) | 3.18114189 |
| 127 | T cell mediated immunity (GO:0002456) | 3.17666685 |
| 128 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.17655666 |
| 129 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.17603297 |
| 130 | positive regulation of interleukin-10 production (GO:0032733) | 3.17236718 |
| 131 | negative regulation of lipid storage (GO:0010888) | 3.16592208 |
| 132 | positive regulation of interleukin-6 production (GO:0032755) | 3.15702699 |
| 133 | tryptophan catabolic process (GO:0006569) | 3.15547652 |
| 134 | indole-containing compound catabolic process (GO:0042436) | 3.15547652 |
| 135 | indolalkylamine catabolic process (GO:0046218) | 3.15547652 |
| 136 | * regulation of immunoglobulin production (GO:0002637) | 3.15109450 |
| 137 | positive regulation of interferon-beta production (GO:0032728) | 3.14906846 |
| 138 | regulation of immunoglobulin secretion (GO:0051023) | 3.14863600 |
| 139 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.14138105 |
| 140 | kynurenine metabolic process (GO:0070189) | 3.13602646 |
| 141 | negative regulation of acute inflammatory response (GO:0002674) | 3.11863470 |
| 142 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.11760029 |
| 143 | T cell activation involved in immune response (GO:0002286) | 3.11747666 |
| 144 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.09838212 |
| 145 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.09255408 |
| 146 | positive T cell selection (GO:0043368) | 3.09096877 |
| 147 | positive regulation of DNA recombination (GO:0045911) | 3.08972324 |
| 148 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08838206 |
| 149 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.08597849 |
| 150 | growth hormone receptor signaling pathway (GO:0060396) | 3.08188364 |
| 151 | * cellular response to molecule of bacterial origin (GO:0071219) | 3.07351959 |
| 152 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.06453108 |
| 153 | dendritic cell differentiation (GO:0097028) | 3.06072127 |
| 154 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.05145794 |
| 155 | positive regulation of natural killer cell activation (GO:0032816) | 3.04074785 |
| 156 | * regulation of isotype switching (GO:0045191) | 3.03932027 |
| 157 | response to muramyl dipeptide (GO:0032495) | 3.01746366 |
| 158 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00633920 |
| 159 | regulation of alkaline phosphatase activity (GO:0010692) | 3.00049840 |
| 160 | cellular response to interferon-gamma (GO:0071346) | 2.99863219 |
| 161 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.99539064 |
| 162 | leukocyte cell-cell adhesion (GO:0007159) | 2.98846422 |
| 163 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.97902909 |
| 164 | * regulation of NF-kappaB import into nucleus (GO:0042345) | 2.96842014 |
| 165 | regulation of antigen processing and presentation (GO:0002577) | 2.96640318 |
| 166 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.95258355 |
| 167 | myeloid dendritic cell activation (GO:0001773) | 2.95172946 |
| 168 | negative regulation of T cell mediated immunity (GO:0002710) | 2.94998323 |
| 169 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94070420 |
| 170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92335632 |
| 171 | regulation of type 2 immune response (GO:0002828) | 2.90019298 |
| 172 | regulation of natural killer cell activation (GO:0032814) | 2.87639731 |
| 173 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.87016065 |
| 174 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.85998728 |
| 175 | * negative regulation of cytokine production involved in immune response (GO:0002719) | 2.85400065 |
| 176 | regulation of defense response to virus by host (GO:0050691) | 2.84738594 |
| 177 | response to interferon-gamma (GO:0034341) | 2.84527239 |
| 178 | cellular response to exogenous dsRNA (GO:0071360) | 2.82970520 |
| 179 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82286543 |
| 180 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.81856171 |
| 181 | positive regulation of interferon-gamma production (GO:0032729) | 2.80160514 |
| 182 | eosinophil chemotaxis (GO:0048245) | 2.80122850 |
| 183 | positive regulation of chemokine production (GO:0032722) | 2.79992669 |
| 184 | * regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.77733309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.71699763 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.03701341 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.26870836 |
| 4 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.11248317 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.93155119 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.60568469 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.58193723 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.54903293 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54085856 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04257246 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98017970 |
| 12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.94120627 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93644021 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80255894 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.73361692 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72759062 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67194943 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57828506 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57420129 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.54292873 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.40493589 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.34643612 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11723393 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11349645 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06507149 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 1.95251588 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.85134379 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79245173 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77137336 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76832657 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75017429 |
| 32 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.72022477 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66418221 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65411368 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63865136 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.63167942 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62553758 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56575447 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53579551 |
| 40 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45177958 |
| 41 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.43445081 |
| 42 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42884110 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41355106 |
| 44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.38828141 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37848236 |
| 46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.37295674 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36279736 |
| 48 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31741112 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.30951058 |
| 50 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30771467 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28830471 |
| 52 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.28171411 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24650544 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23963551 |
| 55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22563063 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22163752 |
| 57 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21214012 |
| 58 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.20458758 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19272103 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18914243 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18363840 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17904046 |
| 63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16976551 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14826950 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14816573 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13444607 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12941814 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10566327 |
| 69 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04770967 |
| 70 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.04212524 |
| 71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02428200 |
| 72 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01993388 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00697889 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00308171 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95853469 |
| 76 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94662988 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94328299 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93215314 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92035353 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91413374 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90715521 |
| 82 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89455641 |
| 83 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.89013019 |
| 84 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.89013019 |
| 85 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.89013019 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88757388 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88208953 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88009094 |
| 89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87906477 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84347231 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83427726 |
| 92 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81634018 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81422298 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80693982 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80416305 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78473892 |
| 97 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77109636 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76711263 |
| 99 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76018774 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75838510 |
| 101 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75786857 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75372666 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73232192 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71656076 |
| 105 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.70530898 |
| 106 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70212313 |
| 107 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.70035817 |
| 108 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66862295 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.66450387 |
| 110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.66020979 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65801452 |
| 112 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.65757575 |
| 113 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.65155737 |
| 114 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64560015 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63601491 |
| 116 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63516112 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.63075408 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63012134 |
| 119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.62298210 |
| 120 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.62298210 |
| 121 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.62236407 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.62141306 |
| 123 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.61741008 |
| 124 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.61613547 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61427682 |
| 126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59583778 |
| 127 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.58137753 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.58058496 |
| 129 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56985946 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.56660191 |
| 131 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.56578453 |
| 132 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.56053126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001873_stomach_inflammation | 6.06431143 |
| 2 | MP0001853_heart_inflammation | 4.21015189 |
| 3 | MP0006082_CNS_inflammation | 3.79288475 |
| 4 | MP0005310_abnormal_salivary_gland | 3.74387569 |
| 5 | * MP0005671_abnormal_response_to | 3.67341907 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.25851433 |
| 7 | MP0003724_increased_susceptibility_to | 3.20222046 |
| 8 | MP0004510_myositis | 3.18606164 |
| 9 | * MP0001800_abnormal_humoral_immune | 3.07759315 |
| 10 | * MP0003303_peritoneal_inflammation | 3.03472131 |
| 11 | MP0003436_decreased_susceptibility_to | 2.97860762 |
| 12 | MP0002933_joint_inflammation | 2.83370884 |
| 13 | MP0009785_altered_susceptibility_to | 2.82017902 |
| 14 | * MP0001790_abnormal_immune_system | 2.77507641 |
| 15 | * MP0005387_immune_system_phenotype | 2.77507641 |
| 16 | * MP0001835_abnormal_antigen_presentation | 2.69842746 |
| 17 | MP0004947_skin_inflammation | 2.64933530 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.55294675 |
| 19 | * MP0002723_abnormal_immune_serum | 2.50051380 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.48643066 |
| 21 | MP0008004_abnormal_stomach_pH | 2.47641194 |
| 22 | * MP0003300_gastrointestinal_ulcer | 2.46944823 |
| 23 | MP0003195_calcinosis | 2.42945347 |
| 24 | * MP0005025_abnormal_response_to | 2.39468983 |
| 25 | MP0002254_reproductive_system_inflammat | 2.34296271 |
| 26 | MP0002405_respiratory_system_inflammati | 2.30353699 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.30329670 |
| 28 | * MP0003763_abnormal_thymus_physiology | 2.28856129 |
| 29 | * MP0001819_abnormal_immune_cell | 2.16045284 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 2.15439387 |
| 31 | MP0001348_abnormal_lacrimal_gland | 2.14261939 |
| 32 | * MP0002419_abnormal_innate_immunity | 1.97348039 |
| 33 | MP0005451_abnormal_body_composition | 1.96135517 |
| 34 | MP0006054_spinal_hemorrhage | 1.93520911 |
| 35 | * MP0002398_abnormal_bone_marrow | 1.86205604 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.85432369 |
| 37 | * MP0002148_abnormal_hypersensitivity_rea | 1.83155401 |
| 38 | * MP0001845_abnormal_inflammatory_respons | 1.82631494 |
| 39 | * MP0000716_abnormal_immune_system | 1.77987267 |
| 40 | MP0000685_abnormal_immune_system | 1.76437391 |
| 41 | * MP0010155_abnormal_intestine_physiology | 1.73605134 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.71794901 |
| 43 | MP0003448_altered_tumor_morphology | 1.63533874 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.63513070 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.62134670 |
| 46 | * MP0001663_abnormal_digestive_system | 1.59217868 |
| 47 | MP0003646_muscle_fatigue | 1.55016119 |
| 48 | * MP0001533_abnormal_skeleton_physiology | 1.53552630 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.52176306 |
| 50 | * MP0002332_abnormal_exercise_endurance | 1.50684471 |
| 51 | * MP0002722_abnormal_immune_system | 1.49857288 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.46437941 |
| 53 | MP0003866_abnormal_defecation | 1.43471298 |
| 54 | MP0002429_abnormal_blood_cell | 1.41309854 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.38843840 |
| 56 | * MP0000703_abnormal_thymus_morphology | 1.36417370 |
| 57 | * MP0008469_abnormal_protein_level | 1.29304982 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.28347005 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.28347005 |
| 60 | MP0000249_abnormal_blood_vessel | 1.27509559 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.23430451 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.21199334 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.18902171 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.18365323 |
| 65 | MP0002006_tumorigenesis | 1.15365664 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.11149516 |
| 67 | MP0005166_decreased_susceptibility_to | 1.07289618 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.05839967 |
| 69 | MP0009764_decreased_sensitivity_to | 1.04910371 |
| 70 | * MP0005381_digestive/alimentary_phenotyp | 1.02708589 |
| 71 | MP0000604_amyloidosis | 1.02576556 |
| 72 | MP0005647_abnormal_sex_gland | 1.01228208 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 1.01205302 |
| 74 | MP0001881_abnormal_mammary_gland | 0.97848693 |
| 75 | MP0003566_abnormal_cell_adhesion | 0.97045602 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.96749536 |
| 77 | MP0009278_abnormal_bone_marrow | 0.96164775 |
| 78 | * MP0000343_altered_response_to | 0.92139112 |
| 79 | * MP0001501_abnormal_sleep_pattern | 0.91033681 |
| 80 | MP0001851_eye_inflammation | 0.88175594 |
| 81 | * MP0005023_abnormal_wound_healing | 0.88001267 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.86676861 |
| 83 | * MP0000490_abnormal_crypts_of | 0.85640711 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.83443378 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.83301031 |
| 86 | MP0003091_abnormal_cell_migration | 0.82135777 |
| 87 | * MP0003075_altered_response_to | 0.82131141 |
| 88 | MP0000627_abnormal_mammary_gland | 0.80050606 |
| 89 | * MP0003795_abnormal_bone_structure | 0.78788056 |
| 90 | MP0009840_abnormal_foam_cell | 0.76686588 |
| 91 | * MP0005535_abnormal_body_temperature | 0.76303910 |
| 92 | MP0000858_altered_metastatic_potential | 0.72694592 |
| 93 | MP0003045_fibrosis | 0.72692685 |
| 94 | MP0004084_abnormal_cardiac_muscle | 0.72037962 |
| 95 | MP0002396_abnormal_hematopoietic_system | 0.71852204 |
| 96 | * MP0009763_increased_sensitivity_to | 0.70814806 |
| 97 | MP0005410_abnormal_fertilization | 0.68363603 |
| 98 | MP0005164_abnormal_response_to | 0.67769710 |
| 99 | MP0003828_pulmonary_edema | 0.66825011 |
| 100 | MP0003690_abnormal_glial_cell | 0.65186438 |
| 101 | MP0004043_abnormal_pH_regulation | 0.63606655 |
| 102 | * MP0005390_skeleton_phenotype | 0.62771150 |
| 103 | * MP0005266_abnormal_metabolism | 0.61658295 |
| 104 | MP0008872_abnormal_physiological_respon | 0.61379831 |
| 105 | MP0003186_abnormal_redox_activity | 0.61063191 |
| 106 | MP0005448_abnormal_energy_balance | 0.60143002 |
| 107 | MP0002277_abnormal_respiratory_mucosa | 0.59701641 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.59052470 |
| 109 | * MP0000477_abnormal_intestine_morphology | 0.58150355 |
| 110 | MP0002009_preneoplasia | 0.55709761 |
| 111 | * MP0008874_decreased_physiological_sensi | 0.52599038 |
| 112 | MP0010307_abnormal_tumor_latency | 0.48884746 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.48663211 |
| 114 | MP0003633_abnormal_nervous_system | 0.47679637 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.47663772 |
| 116 | MP0004883_abnormal_blood_vessel | 0.46491347 |
| 117 | MP0005334_abnormal_fat_pad | 0.46449883 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.46000130 |
| 119 | MP0005379_endocrine/exocrine_gland_phen | 0.45474138 |
| 120 | MP0000598_abnormal_liver_morphology | 0.44844641 |
| 121 | MP0003191_abnormal_cellular_cholesterol | 0.44507025 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.44043218 |
| 123 | * MP0005165_increased_susceptibility_to | 0.42519294 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42456394 |
| 125 | MP0001191_abnormal_skin_condition | 0.42125183 |
| 126 | MP0002098_abnormal_vibrissa_morphology | 0.41446802 |
| 127 | MP0000733_abnormal_muscle_development | 0.41170502 |
| 128 | * MP0000609_abnormal_liver_physiology | 0.39705504 |
| 129 | MP0000920_abnormal_myelination | 0.38665603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the prostate (HP:0008775) | 8.18516589 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 7.31068393 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.31068393 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.31068393 |
| 5 | Ureteral stenosis (HP:0000071) | 7.02584316 |
| 6 | Ureteral obstruction (HP:0006000) | 6.59001985 |
| 7 | Obstructive lung disease (HP:0006536) | 6.58736792 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 6.58736792 |
| 9 | Chest pain (HP:0100749) | 6.18036083 |
| 10 | * Pulmonary infiltrates (HP:0002113) | 5.89291057 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 5.33265650 |
| 12 | Stomatitis (HP:0010280) | 5.18671466 |
| 13 | * Gangrene (HP:0100758) | 5.12528169 |
| 14 | * Vasculitis (HP:0002633) | 5.06072359 |
| 15 | * Pulmonary embolism (HP:0002204) | 5.05999206 |
| 16 | * Hemoptysis (HP:0002105) | 4.84153697 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.73490981 |
| 18 | Disinhibition (HP:0000734) | 4.67726978 |
| 19 | Eczematoid dermatitis (HP:0000976) | 4.63823656 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.63479076 |
| 21 | Loss of speech (HP:0002371) | 4.56430724 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 4.44249046 |
| 23 | Abnormality of male internal genitalia (HP:0000022) | 4.41701988 |
| 24 | Dysostosis multiplex (HP:0000943) | 4.25577492 |
| 25 | Mutism (HP:0002300) | 4.21634227 |
| 26 | Pulmonary fibrosis (HP:0002206) | 4.00451561 |
| 27 | * Thrombophlebitis (HP:0004418) | 3.98163922 |
| 28 | Restrictive lung disease (HP:0002091) | 3.96898551 |
| 29 | Nuclear cataract (HP:0100018) | 3.95398005 |
| 30 | * Glomerulopathy (HP:0100820) | 3.83590154 |
| 31 | * Meningitis (HP:0001287) | 3.82048223 |
| 32 | Epistaxis (HP:0000421) | 3.79551218 |
| 33 | Parakeratosis (HP:0001036) | 3.78824191 |
| 34 | * Abnormality of the pericardium (HP:0001697) | 3.73663244 |
| 35 | IgM deficiency (HP:0002850) | 3.72083817 |
| 36 | Increased IgM level (HP:0003496) | 3.60265560 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.60207364 |
| 38 | B lymphocytopenia (HP:0010976) | 3.58325100 |
| 39 | Abnormality of B cell number (HP:0010975) | 3.58325100 |
| 40 | T lymphocytopenia (HP:0005403) | 3.54360762 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 3.47440319 |
| 42 | * Arterial thrombosis (HP:0004420) | 3.46691190 |
| 43 | * Abnormality of the pleura (HP:0002103) | 3.45997235 |
| 44 | Abnormality of T cell number (HP:0011839) | 3.43730605 |
| 45 | Severe combined immunodeficiency (HP:0004430) | 3.41503023 |
| 46 | * Polyneuropathy (HP:0001271) | 3.39112316 |
| 47 | * Optic neuritis (HP:0100653) | 3.29947870 |
| 48 | * Retrobulbar optic neuritis (HP:0100654) | 3.29947870 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.28524282 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.28524282 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.28524282 |
| 52 | Fatigue (HP:0012378) | 3.27944688 |
| 53 | Recurrent bronchitis (HP:0002837) | 3.26320546 |
| 54 | * Myositis (HP:0100614) | 3.25332415 |
| 55 | Gingival bleeding (HP:0000225) | 3.24772959 |
| 56 | Glomerulonephritis (HP:0000099) | 3.18376273 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 3.13892246 |
| 58 | * Orchitis (HP:0100796) | 3.11106384 |
| 59 | Recurrent abscess formation (HP:0002722) | 3.07445570 |
| 60 | Combined immunodeficiency (HP:0005387) | 3.07187735 |
| 61 | Nausea (HP:0002018) | 2.99422246 |
| 62 | Autoimmune hemolytic anemia (HP:0001890) | 2.97368061 |
| 63 | Inappropriate behavior (HP:0000719) | 2.92444403 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.91854931 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.91661203 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.91661203 |
| 67 | Abnormality of T cells (HP:0002843) | 2.89841423 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.89398090 |
| 69 | Increased serum ferritin (HP:0003281) | 2.86589037 |
| 70 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.85859758 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.81775221 |
| 72 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.79896650 |
| 73 | IgA deficiency (HP:0002720) | 2.78099803 |
| 74 | Apathy (HP:0000741) | 2.73241064 |
| 75 | * Paresthesia (HP:0003401) | 2.70177499 |
| 76 | Joint swelling (HP:0001386) | 2.67879543 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.67096017 |
| 78 | Recurrent viral infections (HP:0004429) | 2.66348570 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.65477116 |
| 80 | Diminished motivation (HP:0000745) | 2.63196850 |
| 81 | Agnosia (HP:0010524) | 2.62905497 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.59098765 |
| 83 | * Pancreatitis (HP:0001733) | 2.57840488 |
| 84 | Diplopia (HP:0000651) | 2.57535487 |
| 85 | Abnormality of binocular vision (HP:0011514) | 2.57535487 |
| 86 | Mesangial abnormality (HP:0001966) | 2.57182794 |
| 87 | Basal ganglia calcification (HP:0002135) | 2.56381392 |
| 88 | Leukocytosis (HP:0001974) | 2.53601052 |
| 89 | Metaphyseal irregularity (HP:0003025) | 2.51751088 |
| 90 | Axonal loss (HP:0003447) | 2.51586426 |
| 91 | * Arthralgia (HP:0002829) | 2.51008079 |
| 92 | Periorbital edema (HP:0100539) | 2.49184947 |
| 93 | Myocardial infarction (HP:0001658) | 2.43034187 |
| 94 | Facial edema (HP:0000282) | 2.42851754 |
| 95 | * Cerebral ischemia (HP:0002637) | 2.41187647 |
| 96 | Peritonitis (HP:0002586) | 2.39967503 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.38950747 |
| 98 | Amaurosis fugax (HP:0100576) | 2.38495296 |
| 99 | Recurrent sinusitis (HP:0011108) | 2.36154449 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 2.36016535 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.35937922 |
| 102 | Skin rash (HP:0000988) | 2.32770692 |
| 103 | Petechiae (HP:0000967) | 2.31071758 |
| 104 | Generalized aminoaciduria (HP:0002909) | 2.25445536 |
| 105 | Thyroiditis (HP:0100646) | 2.24396645 |
| 106 | Abnormality of macrophages (HP:0004311) | 2.24092942 |
| 107 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.23973866 |
| 108 | Abnormal platelet function (HP:0011869) | 2.23874069 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.23874069 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 2.23133854 |
| 111 | Complement deficiency (HP:0004431) | 2.20436581 |
| 112 | IgG deficiency (HP:0004315) | 2.19382448 |
| 113 | Amyloidosis (HP:0011034) | 2.16310247 |
| 114 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13336753 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12838858 |
| 116 | Polycythemia (HP:0001901) | 2.11693816 |
| 117 | Hematuria (HP:0000790) | 2.11170924 |
| 118 | Inflammation of the large intestine (HP:0002037) | 2.10205464 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 2.10082565 |
| 120 | Lymphopenia (HP:0001888) | 2.09816826 |
| 121 | Abnormal platelet volume (HP:0011876) | 2.09080858 |
| 122 | Abnormality of the basal ganglia (HP:0002134) | 2.05965462 |
| 123 | * Keratoconjunctivitis sicca (HP:0001097) | 2.03952627 |
| 124 | Episodic fever (HP:0001954) | 2.00796535 |
| 125 | Interstitial pulmonary disease (HP:0006530) | 2.00531432 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99930350 |
| 127 | Emphysema (HP:0002097) | 1.99536150 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.99383239 |
| 129 | Esophageal varix (HP:0002040) | 1.97866083 |
| 130 | Poor head control (HP:0002421) | 1.97819545 |
| 131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97381275 |
| 132 | Skin ulcer (HP:0200042) | 1.95841681 |
| 133 | Gastrointestinal inflammation (HP:0004386) | 1.95515319 |
| 134 | Pustule (HP:0200039) | 1.94274846 |
| 135 | Purpura (HP:0000979) | 1.93374830 |
| 136 | Increased mean platelet volume (HP:0011877) | 1.92132728 |
| 137 | * Anorexia (HP:0002039) | 1.91850243 |
| 138 | Hepatosplenomegaly (HP:0001433) | 1.91712312 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 1.90133660 |
| 140 | Neuronal loss in central nervous system (HP:0002529) | 1.89625847 |
| 141 | Erythroderma (HP:0001019) | 1.87319500 |
| 142 | * Keratoconjunctivitis (HP:0001096) | 1.85849063 |
| 143 | Periodontitis (HP:0000704) | 1.83953726 |
| 144 | Albinism (HP:0001022) | 1.83681608 |
| 145 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83296616 |
| 146 | Osteolytic defects of the hand bones (HP:0009699) | 1.83296616 |
| 147 | Cerebral inclusion bodies (HP:0100314) | 1.82043990 |
| 148 | Dementia (HP:0000726) | 1.81353840 |
| 149 | Recurrent skin infections (HP:0001581) | 1.81131648 |
| 150 | Chronic otitis media (HP:0000389) | 1.80602248 |
| 151 | Fused cervical vertebrae (HP:0002949) | 1.80165490 |
| 152 | Personality changes (HP:0000751) | 1.78733142 |
| 153 | Hematochezia (HP:0002573) | 1.77938075 |
| 154 | Thoracolumbar scoliosis (HP:0002944) | 1.76840151 |
| 155 | * Memory impairment (HP:0002354) | 1.75434605 |
| 156 | Prolonged bleeding time (HP:0003010) | 1.74721544 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.73481581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK7 | 4.34504637 |
| 2 | NME2 | 3.23616862 |
| 3 | DDR2 | 2.88205682 |
| 4 | MAP4K1 | 2.79795240 |
| 5 | ADRBK2 | 2.71935915 |
| 6 | BMPR2 | 2.48447492 |
| 7 | MAP3K14 | 2.32451324 |
| 8 | MOS | 2.25572686 |
| 9 | TXK | 14.3141236 |
| 10 | JAK3 | 1.91358760 |
| 11 | TBK1 | 1.88307173 |
| 12 | JAK1 | 1.83064056 |
| 13 | JAK2 | 1.71241170 |
| 14 | ITK | 1.67597198 |
| 15 | MAP3K3 | 1.65830150 |
| 16 | ACVR1B | 1.65077194 |
| 17 | IKBKE | 1.64476564 |
| 18 | ZAP70 | 1.62145489 |
| 19 | TYK2 | 1.47759720 |
| 20 | STK10 | 1.42771401 |
| 21 | IRAK4 | 1.34284284 |
| 22 | IKBKB | 1.33669581 |
| 23 | EPHB1 | 1.30532729 |
| 24 | LCK | 1.27691901 |
| 25 | TEC | 1.25807002 |
| 26 | CDC42BPA | 1.18830475 |
| 27 | HCK | 1.10118419 |
| 28 | EPHA3 | 1.09456508 |
| 29 | SYK | 1.08429075 |
| 30 | MAP2K6 | 1.08415547 |
| 31 | FGFR4 | 1.06633219 |
| 32 | CHUK | 1.05069159 |
| 33 | TLK1 | 1.00964490 |
| 34 | FGFR3 | 1.00798515 |
| 35 | IRAK3 | 0.92798077 |
| 36 | BTK | 0.89595779 |
| 37 | PKN1 | 0.88623562 |
| 38 | BLK | 0.88494406 |
| 39 | ABL2 | 0.88131360 |
| 40 | DAPK2 | 0.87761050 |
| 41 | KIT | 0.84374063 |
| 42 | CSK | 0.82797711 |
| 43 | MAP2K3 | 0.81596304 |
| 44 | DYRK3 | 0.80909295 |
| 45 | TGFBR2 | 0.79022657 |
| 46 | ERN1 | 0.75898962 |
| 47 | CDK6 | 0.73631258 |
| 48 | LATS2 | 0.72222048 |
| 49 | FES | 0.68020693 |
| 50 | PRKCQ | 0.66284189 |
| 51 | FRK | 0.65297403 |
| 52 | RIPK4 | 0.62640921 |
| 53 | TAOK3 | 0.62134921 |
| 54 | STK24 | 0.60304616 |
| 55 | MARK3 | 0.55689109 |
| 56 | ALK | 0.55179627 |
| 57 | SIK2 | 0.53236194 |
| 58 | FYN | 0.51976938 |
| 59 | CAMKK2 | 0.50248761 |
| 60 | LYN | 0.49973162 |
| 61 | TRIB3 | 0.48867587 |
| 62 | PIM1 | 0.48767292 |
| 63 | PDK1 | 0.48180990 |
| 64 | LRRK2 | 0.46952061 |
| 65 | PRPF4B | 0.46357282 |
| 66 | GRK6 | 0.45963154 |
| 67 | IRAK1 | 0.45756212 |
| 68 | MAP4K2 | 0.45522223 |
| 69 | CSF1R | 0.43107100 |
| 70 | RPS6KA4 | 0.42580932 |
| 71 | PDPK1 | 0.41762263 |
| 72 | HIPK2 | 0.40981265 |
| 73 | MAPK4 | 0.40065888 |
| 74 | MST4 | 0.40012039 |
| 75 | PRKCH | 0.38342151 |
| 76 | PTK6 | 0.37481965 |
| 77 | FGR | 0.36703694 |
| 78 | MAP3K10 | 0.36585856 |
| 79 | TAOK2 | 0.36131636 |
| 80 | MAP3K13 | 0.35352189 |
| 81 | BMX | 0.34212660 |
| 82 | CDK12 | 0.32940492 |
| 83 | SIK3 | 0.32163088 |
| 84 | PDGFRB | 0.31982790 |
| 85 | ABL1 | 0.31732189 |
| 86 | DAPK3 | 0.31258023 |
| 87 | MAPK7 | 0.30008836 |
| 88 | TAOK1 | 0.29824269 |
| 89 | MAPK11 | 0.29725862 |
| 90 | CLK1 | 0.28688468 |
| 91 | RIPK1 | 0.28466175 |
| 92 | CDK9 | 0.28129411 |
| 93 | PIM2 | 0.25697075 |
| 94 | MELK | 0.25481457 |
| 95 | ARAF | 0.24050164 |
| 96 | MAP3K7 | 0.23951338 |
| 97 | GSK3A | 0.23931048 |
| 98 | DMPK | 0.23468595 |
| 99 | INSR | 0.23066276 |
| 100 | IRAK2 | 0.22169341 |
| 101 | EGFR | 0.21908429 |
| 102 | CDK4 | 0.20952368 |
| 103 | MATK | 0.20290307 |
| 104 | NEK9 | 0.19513231 |
| 105 | IGF1R | 0.18954272 |
| 106 | EIF2AK2 | 0.18466695 |
| 107 | MAP3K1 | 0.18057428 |
| 108 | PRKAA2 | 0.17671954 |
| 109 | RPS6KA5 | 0.16725120 |
| 110 | NLK | 0.16719442 |
| 111 | CAMK1D | 0.14683111 |
| 112 | MAP3K11 | 0.14554062 |
| 113 | TNK2 | 0.14456607 |
| 114 | RPS6KA6 | 0.13115828 |
| 115 | MAPKAPK2 | 0.12764925 |
| 116 | WNK1 | 0.12468404 |
| 117 | PRKCD | 0.12220085 |
| 118 | CDK14 | 0.11939289 |
| 119 | MAPK3 | 0.11607172 |
| 120 | CAMK1G | 0.11524937 |
| 121 | MAP3K5 | 0.11390532 |
| 122 | MAP3K2 | 0.10791721 |
| 123 | INSRR | 0.10486920 |
| 124 | DYRK1B | 0.10478961 |
| 125 | TTN | 0.09921614 |
| 126 | EIF2AK3 | 0.09378479 |
| 127 | MKNK1 | 0.09087399 |
| 128 | TYRO3 | 0.07892866 |
| 129 | MAPK9 | 0.07438785 |
| 130 | GRK5 | 0.06602669 |
| 131 | RPS6KL1 | 0.06597465 |
| 132 | RPS6KC1 | 0.06597465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 5.81213685 |
| 2 | * Asthma_Homo sapiens_hsa05310 | 4.51412485 |
| 3 | * Allograft rejection_Homo sapiens_hsa05330 | 4.24407896 |
| 4 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.65211008 |
| 5 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.29369209 |
| 6 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.15767785 |
| 7 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.03917142 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.69602561 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.54945553 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15571566 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.03537552 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00858781 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96058416 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82963392 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81086276 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74529258 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69703935 |
| 18 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64898611 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63516590 |
| 20 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59024378 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53153129 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51394538 |
| 23 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44380503 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43600268 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37940843 |
| 26 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.37867431 |
| 27 | * Malaria_Homo sapiens_hsa05144 | 1.35730495 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35111886 |
| 29 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27284296 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.26684107 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.23033772 |
| 32 | * Tuberculosis_Homo sapiens_hsa05152 | 1.22891255 |
| 33 | * Pertussis_Homo sapiens_hsa05133 | 1.15029859 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12515172 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12469737 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.09096774 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.07475152 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.04599858 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 0.97350967 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94423583 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87870458 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87465456 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87257543 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86515034 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86369047 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86309924 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85730642 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.84521061 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.81596559 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80675506 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78758761 |
| 52 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.78235782 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77777944 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76360155 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74328078 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73945517 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.73535981 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72578425 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70881057 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69539532 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66191448 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62705974 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.61779183 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59625517 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58110895 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56199089 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56021759 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54934958 |
| 69 | * Amoebiasis_Homo sapiens_hsa05146 | 0.53674485 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53455880 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50637324 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50349282 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.49632637 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.48387184 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48273565 |
| 76 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45516301 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45263382 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44995231 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43382118 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42406434 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41981947 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40069363 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39663383 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39628577 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.39194523 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38552295 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38229963 |
| 88 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35940219 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35797060 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33125463 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.31599201 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.31325981 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31289883 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30605373 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30023152 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28769885 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28756016 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28473493 |
| 99 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25824438 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.25112514 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24737980 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23847423 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.22814153 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22342777 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21347828 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20703102 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.20682018 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.20412433 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20288484 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19380053 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19035127 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.18030984 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18005891 |
| 114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17686401 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17619388 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16796706 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16393233 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.15388651 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.14569725 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12578906 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.10099540 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07374965 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05323263 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03255341 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03034696 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.02843012 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.01773337 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.00289459 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0003453 |

